Eric Risser
Equibles does not estimate personal net worth.
Get an email with a short summary when Macrogenics Inc publishes a filing, an earnings call transcript or a press release.
Get MGNX alertsAbout Eric Risser
Eric Risser is recorded as CEO, Board Member and COO at Macrogenics Inc (MGNX). The newest filing on record that lists Eric Risser as CEO and Board Member at Macrogenics Inc (MGNX) is dated April 8, 2026. The newest filing on record that lists Eric Risser as COO at Macrogenics Inc (MGNX) is dated April 11, 2025. Macrogenics Inc reported in an 8-K filed August 13, 2025 that Eric Risser was appointed Class I director, effective August 13, 2025. Macrogenics Inc reported in an 8-K filed August 13, 2025 that Eric Risser was appointed President and Chief Executive Officer, effective August 13, 2025. The proxy statement of Macrogenics Inc reports total compensation of $2,078,854 for Eric Risser in fiscal 2025, including a base salary of $561,568. Disclosed compensation is on record for 7 fiscal years. Macrogenics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Macrogenics Inc includes Scott Koenig (CEO and Board Member), William K. Heiden (Chairman and Board Member), James Karrels (CFO) and 7 others.
“the Board elected Mr. Risser to serve on the Board as a Class I director, with a term expiring at the 2026 annual meeting of stockholders.”
“Effective as of August 13, 2025 (the "Effective Date"), the Board of Directors (the "Board") of MacroGenics, Inc. (the "Company") appointed Eric Risser to serve as President and Chief Executive Officer.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 8, 2026
-
Current
Start not stated–present
Last confirmed April 8, 2026
-
Current
Start not stated–present
Last confirmed April 11, 2025
-
Macrogenics Inc (MGNX)
Proxy statement
Start not stated–2021-04-02
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Macrogenics Inc
- Scott Koenig CEO, Board Member
- William K. Heiden Chairman, Board Member
- James Karrels CFO
- Jeffrey Peters General Counsel
- Beth Smith Chief Accounting Officer
- Emil Kuriakose Board Member
- Federica O'Brien Board Member
- Margaret A. Liu Board Member
- Meenu Chhabra Karson Board Member
- Michael Vasconcelles Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Macrogenics Inc (MGNX) | President, Chief Executive Officer and Director | $561,568 | $2,078,854 |
| 2022 | Macrogenics Inc (MGNX) | Chief Operating Officer | $460,802 | $1,915,261 |
| 2021 | Macrogenics Inc (MGNX) | Chief Operating Officer | $427,957 | $1,900,075 |
| 2020 | Macrogenics Inc (MGNX) | Chief Operating Officer | $431,077 | $1,251,044 |
| 2019 | Macrogenics Inc (MGNX) | Chief Operating Officer | $387,806 | $1,779,625 |
| 2018 | Macrogenics Inc (MGNX) | Senior Vice President, Business Development and Portfolio Management and Chief Business Officer | $393,404 | $1,884,732 |
| 2017 | Macrogenics Inc (MGNX) | Senior Vice President, Business Development and Portfolio Management and Chief Business Officer | $374,670 | $1,264,962 |